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National guidance and clinical guidelines recommended multidisciplinary teams (MDTs) for cancer services in order to bring
specialists in relevant disciplines together, ensure clinical decisions are fully informed, and to coordinate care effectively. However, the
effectiveness of cancer teams was not previously evaluated systematically. A random sample of 72 breast cancer teams in England was
studied (548 members in six core disciplines), stratified by region and caseload. Information about team constitution, processes,
effectiveness, clinical performance, and members’ mental well-being was gathered using appropriate instruments. Two input variables,
team workload (P¼ 0.009) and the proportion of breast care nurses (P¼ 0.003), positively predicted overall clinical performance in
multivariate analysis using a two-stage regression model. There were significant correlations between individual team inputs, team
composition variables, and clinical performance. Some disciplines consistently perceived their team’s effectiveness differently from the
mean. Teams with shared leadership of their clinical decision-making were most effective. The mental well-being of team members
appeared significantly better than in previous studies of cancer clinicians, the NHS, and the general population. This study established
that team composition, working methods, and workloads are related to measures of effectiveness, including the quality of clinical care.
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The last decade saw substantial changes in cancer care in the
United Kingdom (UK). New health policies, notably Calman-Hine
(Department of Health, 1995) and the National Cancer Plan
(Department of Health, 2000), were introduced, supported by
detailed guidelines for breast (BASO, 1995) and other cancers. The
Improving Outcomes Guidance (IOG) series started with breast
cancer in 1996. It recommended that all breast patients should be
referred to multidisciplinary teams (MDTs) managing a minimum
of 100 new breast cancer patients per year. Expert opinion
(Working Party of the British Breast Group, 1995) also recom-
mended the establishment of specialist MDTs for breast cancer.
These initiatives were stimulated by concerns about comparative
outcomes (Berino et al, 1995, 1999), and by the variability of
cancer care. Observational studies (Chouillet et al, 1994; Sainsbury
et al, 1995b) showed considerable variability in breast service
delivery. Greater specialisation (Gillis and Hole, 1996) and higher
caseloads (Sainsbury et al, 1995a) were both shown to be
associated with survival benefits.
The successful implementation of breast screening (Forrest,
1986) over the period 1989– 1991 exposed a contrast between well-
planned arrangements for screen-detected disease and the
variability of symptomatic services. Prior to screening, typical
services for symptomatic breast patients were provided by general
surgeons (Link, 2000), usually within general surgical outpatient
clinics. Many surgeons treating symptomatic patients were not
recognised as having a special interest in breast conditions.
Decisions on management seldom involved consultants in other
disciplines. The involvement of oncologists depended on referrals
by surgeons.
Over the last decade, this model has largely been replaced by:
 Individual specialisation in breast disease.
 Multiprofessional working based on multidisciplinary breast
teams.
 Increasing demarcation of breast services, with designated
clinics and facilities.
While these changes predated screening in a few locations, most
hospitals implemented them after publication of Calman-Hine in
1995 and the IOG in 1996. A nonrecurring allocation of d10 million
was provided in England (NHS Executive, 1997) to stimulate the
process.
Team working is important in health-care delivery. Primary care
team working has been reported (Wood et al, 1994) to improve
health-care delivery and staff motivation, giving better detection,
treatment, follow-up, and outcome in hypertension (Adorian et al,
1990). Team working improved patients’ access to primary care
(Marsh, 1991) and the deployment of skills and expertise (Marsh,
1991; Hasler, 1994; Bradley, 1996), producing more cost-effective
services (Marsh, 1991). A study (Jansson et al, 1992) monitoring
patient contacts for 6 years after the introduction of team working
attributed improved patient access to primary care to greater
accessibility and continuity provided by teams. The benefits ofReceived 6 February 2003; accepted 15 April 2003
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multidisciplinary treatment in advanced colorectal cancer were
related primarily to the access to, and use of, standardised and up-
to-date therapy (Landheer et al, 2001), the first published study to
examine the relationship between cancer teams and the quality of
care.
A number of elements are crucial to effective team working
(Guzzo and Shea, 1992). Individuals should feel their work is
essential to the team, their roles should be meaningful and
rewarding, and their contributions should be identifiable. Teams
should have intrinsically interesting tasks to perform, clear, shared
objectives, and feedback on whether they achieved them. Team
leader decisions and behaviours influence team effectiveness
(Tannenbaum et al, 1996). Leaders who listened to members and
incorporated their ideas improved team decisions (Norrgren and
Schaller, 1999). When teams have autonomy to determine their
working procedures, this can reduce costs (Kirkhart, 1995).
Research on workplace teams has been dominated by the
theoretical approach (West et al, 1998) summarised in Figure 1,
to examine relationships between team inputs, how teams work
together, and measures of outcome. This model underpinned the
following study of breast teams, which evaluated a large random
sample of breast teams in England.
MATERIALS AND METHODS
Sample teams
The pragmatic recruitment target was half the breast teams in
England (95 teams). Allowing for nonresponders, a sample of 113
teams was randomly selected from the 190 breast teams listed in
the Cancer Relief Macmillan Directory (The Macmillan Directory,
1996). The number in each region represented a constant sampling
proportion, that is, the proportion in that region, relative to
England. Teams were stratified within regions by their annual new
cancer caseloads, with half drawn above and below the regional
mean. Questionnaire data were collected over 12 months from the
middle of 1999 to 2000.
Invitations to participate were sent to lead breast clinicians.
Teams that agreed to participate nominated their preferred contact
person, who completed the first of three questionnaires. This
provided basic information including the names of members in
core disciplines (COG, 1996) (breast surgeons, breast nurses,
clinical and medical oncologists, histopathologists, and radiolo-
gists). Data on team functioning and self-reported effectiveness
were collected through confidential personal questionnaires
returned individually to the researchers. The nominated contact
provided the clinical data for their team. All research tools were
piloted and revised before use.
Measures used
These covered inputs, process, and outcomes. Information on
team inputs was obtained from the basic team questionnaire and
from individual questionnaires. It included both data about the
whole team and individual members, including:
 The team itself: work locations, meetings, history, and
chronology.
 Membership: number and range of professionals in the team.
 Individual involvement: professional background, grade, train-
ing, experience, time commitment and duration of team
membership, and tenure in the Trust.
Team process was assessed for seven categories of team
working. Four were from the Team Climate Inventory (TCI) (West
and Anderson, 1996), an established measure based on the
theoretical model (West et al, 1998). These covered team
participation, clarity of and commitment to team objectives,
emphasis on quality, and support for innovation. Three further
dimensions were included to test a greater range of team
functioning. These were: reflexivity (West, 1996), the extent to
which team members reflected upon objectives, strategies and
processes and made changes accordingly; team innovation, the
extent to which the team introduced innovations in objectives,
work strategies, processes, and relationships; and leadership,
identifying who were the leaders.
Team Outcomes were assessed in three ways; self-reported
effectiveness, clinical performance, and mental well-being.
Self-reported effectiveness was derived from the individual
questionnaires in which each core member rated their team across
a range of dimensions. These were developed for this study using a
stakeholder analysis. This began with a workshop of invited
representatives from all relevant clinical disciplines, commis-
sioners, managers, and patients. They identified 31 measures that
were aggregated into eight effectiveness groups by factor analysis:
 Accessibility of service, communication with patients.
 Accuracy and timing of diagnosis.
 Enabling informed patient choices, maintaining confidentiality.
 Provision of psychosocial support.
 Primary treatment provided.
 Communication within the team.
 Auditing practice and involvement in research.
 Efficient use of resources.
Expert advice and documented evidence were used to identify
suitable markers to assess teams’ clinical performance, with at least
one measure for each key area of activity. These data were
collected for 1 year’s activity of the team, either the calendar year
1998, or the financial year 1998/1999. This was at the discretion of
teams, depending on data availability. The measures were kept as
simple as possible because of anticipated difficulties for the teams
in obtaining these data for a 12-month period.
Diagnosis Two measures were used: that is, the proportion of
new breast cancer patients attending hospital more than twice to
achieve a diagnosis (Harcourt et al, 1998); and the proportion of
new breast cancer patients who had an open biopsy to achieve a
diagnosis (Okamoto et al, 1998).
Therapy Three measures covering surgery, radiotherapy, and
chemotherapy were used, that is, the proportions of new breast
cancer patients who received conservation surgery; in whom
conservation surgery was followed by radiotherapy; and who were
GROUP 
PROCESSES 
OUT PUTS 
Domain
Health Care 
Organisational
context 
Cost effectiveness
health 
INPUTS OUTPUTS 
Environment
Team task
Team composition 
Leadership 
Clarity of objectives 
Participation
Task orientation 
Support for innovation 
Reflexivity
Decision making
Communication/ 
Integration 
Effectiveness-self and
externally rated
Clinical outcomes & 
quality of health care 
Innovation-self and 
externally rated
Team member mental
Team member turnover
Figure 1 Input, process, and output model of team effectiveness.
Breast cancer teams
R Haward et al
16
British Journal of Cancer (2003) 89(1), 15 – 22 & 2003 Cancer Research UK
C
lin
ic
a
l
aged under 70 years, node positive, and received adjuvant
chemotherapy.
Clinical innovation Three measures were used: that is, who were
aged under 70 years, and received induction chemotherapy;
entered patients into any of nine open national clinical trials
(Stiller, 1989, 1994; routinely measured oestrogen receptor status.
Team member well-being was assessed using a standard
psychological measure, the General Health Questionaire GHQ-12
(Goldberg, 1972), widely used for detecting minor psychiatric
disorder. It covers feelings of strain, depression, inability to cope,
anxiety based on insomnia, lack of confidence, and other
psychological problems. This measure had previously been used
in the NHS to study cancer clinicians (Ramirez et al, 1995, 1996), the
mental health of the NHS workforce (Hardy et al, 1999), in which
the GHQ-12 showed good validity against a psychiatric interview.
Data analysis
Each part of the inputs –processes –outputs model was tested in
turn. For the inputs –processes, and inputs –outputs, parts of the
model, the inputs were split into similar types of variable and
entered into a stepwise regression analysis to identify possible
effects on the outcome. Factors that were identified as significant
were entered together in a ‘second-level’ stepwise regression, to
identify only genuinely important relationships. A similar
procedure was used for the processes – outputs part of the model,
except that processes were not used to predict self-reported
effectiveness, as previous studies showed that any relationships
would be largely affected by common method variance. Other
questions involved aggregation of responses from particular
occupational groups within teams.
The aggregate measure of clinical performance was derived from
the individual clinical measures shown in Table 1. It was calculated
by splitting seven of the clinical data variables dichotomously at
their median; teams were assigned a score of 0 if they were in the
‘poorer’ half of the distribution and 1 if they were in the ‘better’
half of the distribution. The overall score was the sum of these, that
is, a value between 0 and 7. This score was analysed using both
ordinary regression and ordinal logistic regression (not shown):
both methods gave the same results, so those for ordinary
regression are reported for consistency.
RESULTS
Response rates and the samples
Of the sample of 113 breast teams 96 (85%) agreed to participate.
For a team to be eligible for inclusion in the analysis, a minimum
spread of responses across core disciplines was deemed to be
essential. This was defined as at least one breast surgeon and
breast nurse together with one member from at least two of the
remaining three core disciplines completing a personal team-
working questionnaire. A total of 72 (75%) teams fulfilled this
requirement (n¼ 548 individual responses) and were included in
the relevant analyses. However, only 61 (85%) of the 72 teams were
also able to provide the required clinical data (n¼ 481 individual
responses) and only these teams were included in the analyses
involving clinical performance.
In the sample of 72 teams, those responding comprised 113
breast surgeons, 122 breast nurses, 108 radiologists, 92 oncologists,
and 113 pathologists. The mean age was 45.5 years (s.d. 8.1). Of
these, 252 were female (46.5%), and six did not give their gender.
The sample of 61 teams was very similar (98 breast surgeons, 104
breast nurses, 97 radiologists, 82 oncologists, and 100 pathologists)
with a mean age of 45.4 years (s.d. 8.2). Of these, 220 were female
(46.3%) and again six did not give their gender. The spread of
disciplines in the teams is shown in Table 2.
The year in which each team was established (team ‘age’) is
shown in Table 3. Most were formed in the 5 years prior to the
study, 1997 was the modal year.
Table 1 Clinical data – summary statistics
Clinical performance variable Mean Standard deviation Minimum Maximum
Cutoffa for aggregate
clinical performance
Total number of new cancer patients 182.25 106.52 57 620 Not used
% patients visiting hospital more than twice for
diagnostic purposes
10.5% 10.9% 0.0% 52.8% o8.5%¼ 1
% patients receiving open biopsy 12.0% 11.9% 0.0% 60.2% o10%¼ 1
% patients receiving lumpectomy 43.4% 17.4% 1.2% 83.7% 444%¼ 1
% patients receiving radiotherapy after a lumpectomy 72.8% 23.8% 0.0% 100.0% 478%¼ 1
% patients under 70 (and node+) receiving chemotherapy as
part of primary management
64.2% 23.6% 0.0% 100.0% 470%¼ 1
% patients under 70 receiving induction chemotherapy 17.9% 18.9% 0.0% 80.0% Not used
Number of clinical trials entered 3.25 2.14 0 9 43¼ 1
Measure oestrogen receptor status routinely 78% of teams measured oestrogen receptor status routinely Yes¼ 1
aBased on median values for each variable, all other values¼ 0.
Table 2 Total core membership of breast teams in the sample
Numbers and proportions of team members in each core discipline
Number of individuals
in that discipline in the team Surgeons Breast nurses Histopathologists Radiologists Clinical oncologists Medical oncologists
0 0 0 0 0 1 (1%) 51 (71%)
1 17 (24%) 23 (32%) 17 (24%) 23 (32%) 47 (65%) 17 (24%)
2 46 (64%) 27 (38%) 26 (36%) 35 (49%) 18 (25%) 4 (5%)
3 9 (12%) 20 (28%) 25 (35%) 11 (15%) 6 (9%) 0
4 0 2 (2%) 3 (4%) 3 (4%) 0 0
5 0 0 1 (1%) 0 0 0
Breast cancer teams
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Team inputs and team processes
One team composition factor was a predictor of team processes;
professional diversity positively predicted reflexivity (b¼ 0.343,
P¼ 0.009, controlling for team size).
Team inputs and self-reported effectiveness
A number of team composition factors predicted self-reported
effectiveness. There was a consistent and significant difference
between disciplines in their perceptions of a number of effective-
ness measures, with breast surgeons and breast nurses rating
consistently higher than other disciplines in their team, as shown
in Table 4. Of the significant individual relationships, team size
positively predicted accurate and timely diagnosis (b¼ 0.254,
P¼ 0.034). Greater professional diversity in the team positively
predicted effectiveness with respect to clinical audit and research
(b¼ 0.428, P¼ 0.001). The proportion of medical oncologists
(note: numbers in this discipline were much lower than others, and
biased towards major centres) positively predicted overall effec-
tiveness and effective internal communication (b¼ 0.243,
P¼ 0.044). The proportions of breast surgeons and medical
oncologists predicted greater effectiveness of psychosocial support
(b¼ 0.230, P¼ 0.039; b¼ 0.297, P¼ 0.008). The proportion of
radiologists negatively predicted psychosocial support (b¼ 0.235,
P¼ 0.035), and the proportion of clinical oncologists negatively
predicted efficient use of resources (b¼ 0.241, P¼ 0.041).
Team inputs and clinical performance
In multivariate analysis, two input variables predicted the
aggregated measure of clinical performance: the proportion of
breast care nurses in the team and workload (caseload per Whole
Time Equivalent team member) positively predicted clinical
effectiveness (b¼ 0.376, P¼ 0.003 and b¼ 0.331, P¼ 0.009, respec-
tively). In univariate analysis, there was a significant correlation
(r¼ 0.262, P¼ 0.045) between new cancer caseload and aggregated
clinical performance. The partial correlation, controlling for team
size, was 0.319, P¼ 0.015. Thus, even when controlling for team
size, a larger caseload positively predicted better clinical perfor-
mance.
Significant relationships were also found between team inputs
and individual clinical performance measures, summarised in
Table 5.
The frequency of open surgical biopsies was positively predicted
by the proportion of histopathologists in the team (b¼ 0.285,
P¼ 0.024), but the number of breast care nurses was associated
with fewer open surgical biopsies (b¼0.333, P¼ 0.009). The
number of hospitals where breast clinics were held had a negative
impact on the speed of diagnosis, and was positively associated
with the percentage of patients visiting hospital for diagnosis on
more than one occasion (b¼ 0.416, P¼ 0.006). However, where
breast clinics were held in more hospitals, this was positively
associated with the percentage of patients entered into clinical
trials (b¼ 0.323, P¼ 0.016). Recruitment into clinical trials was
positively predicted by the number of patients seen (b¼ 0.312,
P¼ 0.018), and negatively predicted by the mean age of team
members (b¼0.330, P¼ 0.010).
The use of lumpectomies was positively predicted by workload
(b¼ 0.292, P¼ 0.029). However, greater number of hospitals where
teams were based and more medical oncologists in the team were
associated with fewer lumpectomies (b¼0.342, P¼ 0.011 and
b¼0.294, P¼ 0.024, respectively). The use of radiotherapy after
lumpectomy was found to be positively related to the age of the
team (b¼ 0.482, Po0.001), the number of medical oncologists in
the team (b¼ 0.317, P¼ 0.018), and the number of hospitals where
teams were based (b¼ 0.308, P¼ 0.012). Induction chemotherapy
was more frequent in teams with a greater age diversity (b¼ 0.324,
P¼ 0.028), and in teams with more medical oncologists.
Team process and effectiveness
Leadership results are summarised in Table 6. The number of
different occupational groups reported by team members as
leading team discussion positively predicted team processes and
team effectiveness. This dispersed leadership predicted participa-
tion, concern for quality and reflexivity, self-rated innovation, and
overall effectiveness. Lack of clarity about leadership and conflict
over leadership both negatively predicted team processes, parti-
cipation, support for innovation, and mean team-working score. In
addition, lack of clarity about leadership negatively predicted
clarity of objectives, overall team effectiveness, efficient use of
resources, and effective communication with patients. Conflict
Table 3 ‘Age’ of teams in sample
Year of formationa Number of teams
1980–1984 2 0.4 pab
1985–1989 6 1.2 pa
1990–1994 16 3.2 pa
1995–1999 47 9.4 pa
Breakdown of 1995–99
1995 8
1996 9
1997 14
1998 9
1999 7
aYear in which regular team meetings began, bPer annum.
Table 4 Effect of discipline on perceived effectiveness
Discipline
Higher rating of their
team effectiveness Discipline
Lower rating of their
team effectiveness
Breast surgeon Overall effectiveness Histopathologist Overall effectiveness*
Task orientation Innovation
Reflexivity S-R effectiveness
Innovation 4* out of 8
5 out of 8 S-R effectiveness Radiologist Overall effectiveness*
Breast Nurse Overall effectiveness* S-R effectiveness
Reflexivity 5* out of 8
Support for innovation*
Innovation*
S-R effectiveness
All 8 (6 at *)
All significant at 5% level, or * at 1% level. S-R¼ self-rated.
Breast cancer teams
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over leadership and lack of clarity about leadership were both
negative predictors of effective internal communication within the
team and effectiveness with respect to audit and research. Having a
single, clear leader negatively predicted support for innovation, the
mean team-working score, and effectiveness with respect to audit
and research.
Mental health in breast cancer teams
The prevalence of minor psychiatric morbidity among members of
breast cancer care teams shown in Table 7 was substantially and
significantly lower than has been previously observed for people
working in other types of health teams, in the NHS workforce
generally, and in sample studies of the UK population. Only one
measure of team inputs, greater age diversity in the team,
predicted better mental health (b¼ 0.317, P¼ 0.007). This held
when age was controlled for.
DISCUSSION
All three categories, team inputs, processes, and outcomes
contained substantial numbers of variables, highlighting the
potential for spurious significance results arising from the large
numbers of individual comparisons possible within the data. Prior
hypotheses were therefore developed about potential relationships
Table 5 Summary of relationships between team inputs and individual clinical performance measures
Input variable Clinical performance b P
Team task
Higher workload Greater % patients receiving lumpectomies 0.292 0.029
Greater number of patients seen More patients entered into clinical trials 0.312 0.018
Greater number of hospitals where breast
clinics are held
Greater percentage of patients visiting hospital for diagnosis
on more than one occasion
0.416 0.006
Greater percentage of patients entered into clinical trials 0.323 0.016
Greater number of hospitals where
teams are based
Fewer lumpectomies 0.342 0.011
More radiotherapy after lumpectomy 0.308 0.012
Greater team age More radiotherapy after lumpectomy 0.482 o0.001
Team composition
More breast care nurses in the team Fewer open surgical biopsies 0.333 0.009
More medical oncologists Fewer lumpectomies 0.294 0.024
More radiotherapy after lumpectomy 0.317 0.018
More patients under 70 years receiving chemotherapy 0.341 0.022
Greater proportion of histopathologists More open surgical biopsy 0.285 0.024
Greater age diversity Greater% of patients under 70 years receiving induction chemotherapy 0.324 0.028
Higher mean age of team members Fewer patients entered in clinical trials 0.330 0.010
b¼ standardised coefficient in the regression equation; P¼ statistical significance.
Table 6 Relationships between leadership and team effectiveness
Leadership variable Dependent variable b P
Having a number of leaders Participation 0.305 0.016
Focus on quality 0.374 0.012
Reflexivity 0.420 0.005
Innovation (self-rated) 0.224 0.041
Effectiveness (overall) 0.258 0.018
Lack of clarity over leadership Participation 0.470 o0.001
Support for innovation 0.538 o0.001
Mean TCI score 0.573 o0.001
Clarity of objectives 0.430 0.004
Innovation (self-rated) 0.392 0.001
Effectiveness (overall) 0.382 0.001
Effectiveness – audit/research 0.511 o0.001
Efficient use of resources 0.480 o0.001
Effective comm. with patients 0.296 0.012
Effective internal comm. 0.431 o0.001
Conflict over leadership Participation 0.312 0.014
Support for innovation 0.515 o0.001
Mean TCI score 0.453 0.001
Effectiveness – audit/research 0.287 0.007
Effective internal comm. 0.367 0.001
Having a single, clear leader Support for innovation 0.414 0.002
Mean TCI score 0.384 0.004
Effectiveness – audit/research 0.353 0.002
b¼ standardised coefficient in the regression equation; P¼ statistical significance; TCI¼Team Climate Inventory.
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within the data, based on studies of teams in other contexts and
expert advice about what might be anticipated in breast cancer.
This reduced but could not eliminate this problem.
A second concern was attributing causality in significantly
correlated relationships within the data, which necessitated
caution in interpreting apparently significant findings. For
example, predictions involving medical oncology were based on
less than a third of teams having a medical oncologist (29% of the
72 sample, 31% of the 61 sample). This distribution was almost
certainly not random because of the preponderance of academic
departments of medical oncology (mainly in cancer centres).
Four main conclusions were drawn from this study:
 Important relationships existed between team composition and
outcome (both perceived team effectiveness and clinical
performance).
 Higher breast cancer workload predicted better clinical
performance.
 Leadership styles were important to team effectiveness.
 Mental health was substantially better in breast team members
than in other NHS settings or the wider population.
Inputs and effectiveness
The IOG (1996) concluded that there was considerable support for
the role of breast nurses, but lacked evidence of their effectiveness.
The finding that the proportion of breast nurses strongly predicted
(P¼ 0.003) aggregated clinical performance in this study has
provided important corroboration of their value. It shows that they
improved the quality of clinical care, exerting a positive influence
on the work of their teams and hence on their medical colleagues.
An example was the negative relationship of the number of breast
nurses to the proportion of open surgical biopsies. This procedure
was once common, but has been gradually replaced by more
appropriate and acceptable methods for patients. Breast nurses,
whose role includes advocacy of their patient’s interests, might
have been expected to influence their surgical colleagues and hence
accelerate the decline of this procedure. The study results were
consistent with this interpretation.
Few relationships were found between team composition and
team processes, less than in other types of teams studied (Borrill
et al, 2000). However, professional diversity in the team and
reflexivity were positively related (Po0.009), supporting one of the
underlying rationales for bringing different occupational groups
together in teams. This being that a greater range of knowledge
and experience available to the team would promote discussion,
opportunities for learning, and lead to improved services. Entry of
patients into clinical trials was more common in teams in which
the mean age was younger, perhaps reflecting more recent training
and professional enthusiasm. Age diversity also had a positive
influence on clinical innovation, using induction chemotherapy as
a marker.
The length of time a team had worked together was an
important influence (P¼o0.001) on its ability to ensure patients
actually received radiotherapy following conservation surgery.
This suggests that teams needed time working together if they were
to achieve reliable coordination of different elements of service
delivery, and that working together clearly improved their teams’
clinical performance over time. This is important because of the
value of radiotherapy in achieving good local control (Wong and
Harris, 2001). The variability in radiotherapy utilisation shown in
Table 1 was consistent with evidence from descriptive studies
(Sainsbury et al, 1995b).
The extent to which teams worked across different hospitals did
not have a consistent impact on their quality of care. Holding
breast clinics in more hospitals led to more patient visits for
diagnostic purposes (P¼ 0.006), an indication of poorer quality of
care. This might be a consequence of diagnostic services being
stretched or disrupted by these arrangements. However, entry into
clinical trials was greater when clinics were in more hospitals
(P¼ 0.016), which may be explained by the nature of the split site
arrangements. For example, combining breast services between
smaller hospitals and academic hospitals might promote trial
entry. Of the hospitals described as the main base for breast teams
spanning two or more hospitals, 40% were university hospitals or
cancer centres (data not shown). Basing teams in more than one
hospital was less satisfactory, with lower rates of conservation
surgery (P¼ 0.011); however, the likelihood of radiotherapy after
lumpectomy was paradoxically greater (P¼ 0.012).
Profession and discipline
Perceptions of team effectiveness were strongly influenced by the
profession/discipline of members, and showed a clear pattern.
Breast surgeons and breast nurses had a significantly more positive
perception of their team’s effectiveness across a range of
dimensions than the mean. By contrast, histopathologists and
radiologists had a consistently more negative perception. Oncol-
ogists were not significantly different from the mean. One
hypothesis based on their degree of involvement seemed plausible.
For breast surgeons and breast nurses, the breast team was central
to their work and professional lives. Most oncologists manage
patients with a number of cancer types (typically three), involving
membership of an identifiable team. Consequently, their commit-
ment to any one team might be expected to be weaker than breast
surgeons and nurses who only worked in one. However, the
weakest level of commitment to the breast team might be expected
among those histopathologists and radiologists who belonged to
several other cancer teams as well as having obligations to the
running of their departments. This interpretation is consistent
with the evidence from this study.
The policy objective of site specialisation among pathologists
and radiologists was intended to develop expertise, with higher
standards of reporting, and improved diagnostic inputs to clinical
decisions (Department of Health, 1995, 2000) and guidance (BASO,
1995; IOG, 1996). However, the requirement for named patholo-
gists/radiologists for each specialist cancer team increased the
practical obstacles to full individual participation in any one team.
Both disciplines are acknowledged (Department of Health, 2000) to
be in short supply. Pressure to site-specialise may have reduced
operational flexibility, particularly in smaller departments. Inade-
quate site specialisation in these disciplines would lead to all or
most consultants reporting breast results, and hence being listed as
breast team members. Table 2 shows that 40% of teams listed three
or more histopathologists, and 19% three or more radiologists,
figures suggestive of inadequate site specialisation. Teams with
more members in these disciplines were significantly less effective
for two measures; more radiologists negatively related to
psychosocial support; more pathologists related to more open
surgical biopsy.
Table 7 Comparison of mental health (casenessa) between breast teams
and the NHS, other health teams, and the population (Mullarky et al, 1999)
Comparison group Casenessa level
NHS workforce 26.6%
Community mental health teams 25.5%
Secondary-care teams 23.3%
Primary health-care teams 22.2%
British Household Panel Survey 20.6%
Breast cancer teams 15.7% Po0.005
(CI 12.7–18.7%)
aA case is defined as someone who answers in the upper two categories for at least
four of the GHQ items. CI is the 95% confidence interval.
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Workload, caseload, and clinical performance
This study showed that workload (new cancer annual caseload of
the team related to the actual time committed by each breast team
member) predicted the quality of clinical care provided by the
team as a whole, based on the aggregate measure of clinical
performance (P¼ 0.009). Notably, it showed that benefit from
higher workload was progressive rather than a step effect. Caseload
was also significantly correlated in univariate analysis and showed,
for a given team size, that higher caseload led to better clinical
performance. These data add to other evidence about volume,
specialisation and outcome in breast cancer (Sainsbury et al,
1995a; Gillis and Hole, 1996). In all, 12 further studies were listed
in the evidence review (IOG, 1996), mostly from cancer registries
or administrative databases. Univariate analysis also showed that
greater numbers of patients was related to greater involvement in
clinical trials (P¼ 0.018). Overall, this evidence supported national
guidance (IOG, 1996) and clinical guidelines (BASO, 1995) that
sufficient workload is necessary for breast teams to be viable and
effective.
Leadership and team effectiveness
The term leadership was used to describe leadership within team
meetings, and focused on clinical decision-making. The style of
leadership was important to the effectiveness of teams. The most
effective model, which positively and strongly correlated with
five measures (participation, focus on quality, overall effectiveness,
self-rated innovation, and reflexivity), was that of a number of
leaders within the team, that is plural, democratic, or distributed
leadership. This has important implications for breast
team development. It also emphasised the importance of the
distinction between the (usually) single administrative head of
each team, necessary for management, and the shared leadership
style within the team which worked best for clinical decision-
making.
Lack of clarity or conflict about leadership was strongly and
negatively related to effectiveness. This was particularly evident for
‘lack of clarity’, which showed significant negative findings for 10
measures (half at o(P¼ )0.001 level). Conflict was a strong
negative predictor across five measures (with P-values between
o0.001 and 0.014). The alternative of one clear leader had a
negative correlation with innovation and effectiveness in audit/
research (both P-values 0.002), and mean TCI score (P¼ 0.004).
This suggested that single leaders might be autocratic, in the sense
that other viewpoints within the team, which, if expressed, could
lead to better decision-making, innovation, and change, did not
flourish under this leadership style. Having a single leader was
however better for the team than conflict or lack of clarity about
leadership.
Mental health of breast teams members
The results showed psychiatric morbidity significantly below those
in previous studies of NHS teams, the NHS workforce, the
population as a whole, and particularly in studies of cancer
clinicians in the era prior to the widespread adoption of teams in
cancer care. Ramirez et al (1995) had suggested that there might be
latent problems among cancer clinicians of ‘burn-out’ or
psychiatric morbidity. For this reason, it was appropriate to
include this topic in personal questionnaires. Ramirez et al (1995,
1996) had found a prevalence of 27% psychiatric morbidity in 1133
hospital consultants, largely surgeons, radiologists, and oncolo-
gists using the same instrument as this study, the GHQ-12, with a
prevalence for cancer clinicians only of 28%. The results for breast
teams in this sample were very different from those previously
described and warrant further study.
There were three possible interpretations for this finding, which
were not exclusive. The most likely was that team working was
beneficial to the mental health of its members, allowing problems
and pressures to be shared, and individuals to be supported by
colleagues. Secondly, working in breast cancer may have been a
more positive experience relative to other cancers, with a higher
disease profile and better prognosis than most solid tumours. The
third possibility was selection bias. Could those breast teams (and
individuals within them) that participated, and returned their
personal questionnaires, be different from the remainder? There
seems no obvious reason to attribute different motivations to those
completing questionnaires in this study to those responding to
Ramirez (Ramirez et al, 1995, 1996).
Multidisciplinary teams have been repeatedly identified as
central to the delivery of cancer services. They provide the
principal mechanism to ensure that the expertise of each relevant
discipline and professional group are brought together, contribut-
ing to, and participating in, decisions on the management of all
patients with a particular cancer type. This study demonstrated
that a number of the characteristics of breast teams affected their
clinical performance and effectiveness. These findings should
facilitate the development of breast teams to maximise their
effectiveness. Further studies are required to assess the extent to
which these findings might apply more generally to teams
managing patients with other cancers, or providing palliative care.
The possible beneficial effect on mental well-being warrants
further investigation.
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